BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17403112)

  • 1. Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions.
    Guéant-Rodriguez RM; Juillière Y; Nippert M; Abdelmouttaleb I; Herbeth B; Aliot E; Danchin N; Guéant JL
    J Thromb Haemost; 2007 Jun; 5(6):1209-16. PubMed ID: 17403112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients.
    Bokhari SW; Bokhari ZW; Zell JA; Lee DW; Faxon DP
    Coron Artery Dis; 2005 May; 16(3):153-61. PubMed ID: 15818084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Am J Cardiol; 2005 Mar; 95(5):553-7. PubMed ID: 15721090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between plasma brain natriuretic peptide level and left ventricular systolic function in coronary artery disease].
    Celiński R; Grzywa-Celińska A; Cholewiński W; Stefaniak B; Tarkowska A
    Pol Merkur Lekarski; 2005 Mar; 18(105):291-4. PubMed ID: 15997635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma BNP levels and left ventricular diastolic function as measured by radionuclide ventriculography in patients with coronary artery disease.
    Celiński R; Cholewiński W; Stefaniak B; Tarkowska A
    Nucl Med Rev Cent East Eur; 2004; 7(2):123-8. PubMed ID: 15968598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.
    Vanzetto G; Jacon P; Calizzano A; Neuder Y; Faure P; Fagret D; Machecourt J
    J Nucl Cardiol; 2007; 14(6):835-42. PubMed ID: 18022110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
    Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
    Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Thanapiboonpol P; Nakyen S; Udompunturak S
    J Card Fail; 2008 Oct; 14(8):687-94. PubMed ID: 18926441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
    Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
    Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease.
    May HT; Alharethi R; Anderson JL; Muhlestein JB; Reyna SP; Bair TL; Horne BD; Kfoury AG; Carlquist JF; Renlund DG
    Cardiology; 2007; 107(3):178-84. PubMed ID: 16940722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.
    Letsas KP; Filippatos GS; Pappas LK; Mihas CC; Markou V; Alexanian IP; Efremidis M; Sideris A; Maisel AS; Kardaras F
    Clin Res Cardiol; 2009 Feb; 98(2):101-6. PubMed ID: 18975023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
    Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
    Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between coronary collateral circulation and plasma levels of N-terminal pro-B-type natriuretic peptide].
    Kadı H; Ceyhan K; Celik A; Koç F
    Anadolu Kardiyol Derg; 2011 Feb; 11(1):29-33. PubMed ID: 21183415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of change in 5-year N-terminal fragment of the prohormone brain-type natriuretic peptide with left ventricular structure and function in stable coronary disease.
    Psotka MA; Schiller NB; Whooley MA; Mishra RK
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19(2):67-72. PubMed ID: 29251695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.